Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Dor BioPharma and Fusion Capital sign stock purchase agreement
Fusion Capital has purchased 2.78 million shares together with a warrant to purchase up to 1.39 million shares of Dor common stock at $0.22 per share, for an
Fusion Capital has purchased 2.78 million shares together with a warrant to purchase up to 1.39 million shares of Dor common stock at $0.22 per share, for an
Initially consisting of 1800 antibodies, the library is expected to grow by several thousand per year with the goal of producing at least one antibody to all 22,000
The purchase agreement was completed in conjunction with the formation of a worldwide collaboration and licensing agreement with Pfizer for the discovery, development and commercialization of compounds which
Albireo has secured one clinical and a number of preclinical gastrointestinal (GI) programs from AstraZeneca as well as several researchers with extensive experience in AstraZeneca’s GI Research Area.
The company has divisionalized Signalcare for the time being, and will evaluate placing Signalcare into a wholly-owned subsidiary after developments and relationships have materialized or have become formalized.
Dendreon’s researchers evaluated cumulative product release parameters of Provenge, including CD54 upregulation (a measure of product potency defined as the increase of CD54 molecules expressed on Antigen Presenting
The plan also calls for the expansion of business development initiatives to evaluate partnership opportunities across the company’s product pipeline and the streamlining of operations through an expense-reduction
The notice of allowance is the USPTO’s official communication that the company’s application has successfully completed examination and that a patent will be issued. Once issued, the patent
This is the second oral healthcare product in their portfolio. The products will be available for distribution in the dental and consumer marketplaces with applications including halitosis, gingivitis,
The new data reveals that Advitech’s fraction is capable of enhancing biochemical activity of fibroblasts (relative to cell proliferation and collagen synthesis) while preventing physiological phenomena that can